CA
CVS icon

Cortland Associates’s CVS Health CVS Stock Holding History

Cortland Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5,415
Closed -$321K – 55
2020
Q1 		$321K Sell
5,415
-460,781
-99% -$30.8M 0.06% 37
2019
Q4 		$34.6M Buy
466,196
+31,897
+7% +$2.24M 4.9% 10
2019
Q3 		$27.4M Sell
434,299
-53,213
-11% -$3.15M 4.85% 12
2019
Q2 		$26.6M Sell
487,512
-10,884
-2% -$586K 4.2% 12
2019
Q1 		$26.9M Buy
498,396
+1,680
+0.3% +$104K 4.34% 12
2018
Q4 		$32.5M Sell
496,716
-14,090
-3% -$1.05M 5.91% 9
2018
Q3 		$40.2M Sell
510,806
-10,118
-2% -$723K 6.23% 8
2018
Q2 		$33.5M Sell
520,924
-2,303
-0.4% -$152K 5.43% 9
2018
Q1 		$32.5M Buy
523,227
+9,997
+2% +$717K 5.74% 10
2017
Q4 		$37.2M Buy
513,230
+12,304
+2% +$895K 6.78% 7
2017
Q3 		$40.7M Sell
500,926
-21,096
-4% -$1.67M 7.6% 5
2017
Q2 		$42M Sell
522,022
-10,378
-2% -$819K 8.06% 6
2017
Q1 		$41.8M Sell
532,400
-4,874
-0.9% -$389K 8.46% 3
2016
Q4 		$42.4M Sell
537,274
-5,733
-1% -$464K 8.61% 4
2016
Q3 		$48.3M Buy
543,007
+12,595
+2% +$1.19M 9.8% 3
2016
Q2 		$50.8M Sell
530,412
-3,172
-0.6% -$316K 11.14% 2
2016
Q1 		$55.3M Buy
533,584
+122,372
+30% +$11.9M 11.57% 1
2015
Q4 		$40.2M Buy
411,212
+62,063
+18% +$6.08M 7.8% 5
2015
Q3 		$33.7M Sell
349,149
-5,928
-2% -$623K 7.82% 5
2015
Q2 		$37.2M Sell
355,077
-2,618
-0.7% -$267K 7.85% 5
2015
Q1 		$36.9M Buy
357,695
+1,696
+0.5% +$172K 7.61% 5
2014
Q4 		$34.3M Sell
355,999
-568
-0.2% -$50K 7.03% 6
2014
Q3 		$28.4M Buy
356,567
+115,767
+48% +$9.13M 6.76% 6
2014
Q2 		$18.1M Sell
240,800
-2,797
-1% -$211K 3.62% 13
2014
Q1 		$18.2M Buy
243,597
+4,471
+2% +$316K 3.73% 13
2013
Q4 		$17.1M Sell
239,126
-10,266
-4% -$660K 3.48% 13
2013
Q3 		$14.2M Sell
249,392
-192,771
-44% -$11.5M 3.03% 14
2013
Q2 		$25.3M Buy
+442,163
New +$25.6M 5.73% 6

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Cortland Associates's CVS Position: Q2 2020 in Review

Cortland Associates sold out of CVS Health (CVS) in Q2 2020, closing a stake of 5,415 shares — an estimated $321K sold.

Cortland Associates first reported a position in CVS in Q2 2013 and held it in 28 quarters. The position peaked at $55.3M in Q1 2016. 1,864 funds tracked by Wall St. Rank hold CVS as of Q2 2020.

  • Cortland Associates reported no remaining CVS Health position as of Q2 2020 after selling out during the quarter.
  • Cortland Associates sold 5,415 CVS Health shares in Q2 2020, an estimated $321K.
  • Cortland Associates first reported a position in CVS Health in Q2 2013 and held it in 28 quarters.
  • Cortland Associates's CVS Health position peaked at $55.3M in Q1 2016.
  • 1,864 funds tracked by Wall St. Rank held CVS Health as of Q2 2020.

Based on Cortland Associates's 13F filing for Q2 2020, filed 23 Jul 2020.